NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Roger Stupp*, Eric T. Wong, Andrew A. Kanner, David Steinberg, Herbert Engelhard, Volkmar Heidecke, Eilon D. Kirson, Sophie Taillibert, Frank Liebermann, Vladimir Dbalý, Zvi Ram, J. Lee Villano, Nikolai Rainov, Uri Weinberg, David Schiff, Lara Kunschner, Jeffrey Raizer, Jerome Honnorat, Andrew Sloan, Mark MalkinJoseph C. Landolfi, Franz Payer, Maximilian Mehdorn, Robert J. Weil, Susan C. Pannullo, Manfred Westphal, Martin Smrcka, Lawrence Chin, Herwig Kostron, Silvia Hofer, Jeffrey Bruce, Rees Cosgrove, Nina Paleologous, Yoram Palti, Philip H. Gutin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

604 Scopus citations

Fingerprint

Dive into the research topics of 'NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience